ZA906970B - Topical,antiinflammatory compositions with minimal systemic absorption - Google Patents

Topical,antiinflammatory compositions with minimal systemic absorption

Info

Publication number
ZA906970B
ZA906970B ZA906970A ZA906970A ZA906970B ZA 906970 B ZA906970 B ZA 906970B ZA 906970 A ZA906970 A ZA 906970A ZA 906970 A ZA906970 A ZA 906970A ZA 906970 B ZA906970 B ZA 906970B
Authority
ZA
South Africa
Prior art keywords
topical
systemic absorption
minimal systemic
antiinflammatory compositions
antiinflammatory
Prior art date
Application number
ZA906970A
Other languages
English (en)
Inventor
Bruce Jeffrey Aungst
Jeffrey Aungst Bruce
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of ZA906970B publication Critical patent/ZA906970B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/14—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with at least one hydroxy group on a condensed ring system containing two rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
    • C07C49/835—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups having unsaturation outside an aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/13—Burn treatment

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA906970A 1989-08-31 1990-08-31 Topical,antiinflammatory compositions with minimal systemic absorption ZA906970B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/400,404 US5091379A (en) 1989-08-31 1989-08-31 Topical antinflammatory compositions with minimal systemic absorption

Publications (1)

Publication Number Publication Date
ZA906970B true ZA906970B (en) 1992-05-27

Family

ID=23583474

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA906970A ZA906970B (en) 1989-08-31 1990-08-31 Topical,antiinflammatory compositions with minimal systemic absorption

Country Status (10)

Country Link
US (1) US5091379A (xx)
EP (1) EP0493404A4 (xx)
JP (1) JPH05501871A (xx)
AU (1) AU636547B2 (xx)
CA (1) CA2064189A1 (xx)
IE (1) IE903163A1 (xx)
IL (1) IL95528A (xx)
NZ (1) NZ235081A (xx)
WO (1) WO1991003227A1 (xx)
ZA (1) ZA906970B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6086905A (en) * 1991-03-21 2000-07-11 Peck; James V. Topical compositions useful as skin penetration barriers
US5505948A (en) * 1993-06-01 1996-04-09 Dermatology Home Products, Inc. Home skin peel composition for producing healthy and attractive skin
US5703104A (en) * 1995-07-07 1997-12-30 Durham Pharmaceuticals Llc Cyclic amides and derivatives thereof
DE19746250A1 (de) * 1997-10-20 1999-04-22 Henkel Kgaa Verwendung von substitutierten alpha-Naphtolen zum Färben von Keratinfasern
US20020006913A1 (en) 1997-11-04 2002-01-17 Von Borstel Reid W. Antimutagenic compositions for treatment and prevention of photodamage to skin
US6203796B1 (en) 1999-07-08 2001-03-20 Andreas D. Papaprodromou Oregano-based therapeutic composition
US6835184B1 (en) * 1999-09-24 2004-12-28 Becton, Dickinson And Company Method and device for abrading skin

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL105672C (xx) *
US4473565A (en) * 1976-05-13 1984-09-25 Johnson & Johnson Topical anti-inflammatory drug therapy
CA1196284A (en) * 1982-05-28 1985-11-05 Joshua Oduro-Yeboah Pharmaceutical formulations
CA1236029A (en) * 1984-05-14 1988-05-03 Edmund Sandborn Pharmaceutical solutions comprising dimethyl sulfoxide
US4895727A (en) * 1985-05-03 1990-01-23 Chemex Pharmaceuticals, Inc. Pharmaceutical vehicles for exhancing penetration and retention in the skin
US4833164A (en) * 1985-05-08 1989-05-23 E. I. Du Pont De Nemours And Company 2-substituted-1-naphthols, pharmaceutical compositions of, and their use as 5-lipoxygenase inhibitors
GB8621008D0 (en) * 1986-08-30 1986-10-08 Smith & Nephew Ass Pharmaceutical composition
US5093351A (en) * 1989-01-05 1992-03-03 Du Pont Merck Pharmaceutical Company Substituted indole, benzofuran and benzothiophene derivatives as 5-lipoxygenase inhibitors

Also Published As

Publication number Publication date
WO1991003227A1 (en) 1991-03-21
US5091379A (en) 1992-02-25
JPH05501871A (ja) 1993-04-08
IL95528A (en) 1994-07-31
AU636547B2 (en) 1993-04-29
NZ235081A (en) 1992-10-28
AU6289990A (en) 1991-04-08
EP0493404A4 (en) 1992-08-12
CA2064189A1 (en) 1991-03-01
EP0493404A1 (en) 1992-07-08
IE903163A1 (en) 1991-03-13

Similar Documents

Publication Publication Date Title
GB2192539B (en) Topical diclofenac compositions with systemic action.
GR3015811T3 (en) 3-substituted-2-oxindole derivatives as antiinflammatory agents.
GB2218334B (en) Cyclosprorin compositions for topical application
HU896808D0 (en) Antibactericid, antiplaque composition
AU586182B2 (en) Analgesic 1,2-Benzisothiazol-3-ylpiperazine derivatives
EP0457333A3 (en) Topical composition
AU2964589A (en) Topical l-carnitine composition
GB8828018D0 (en) Topical composition
AU556948B2 (en) Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
AU565087B2 (en) 1,4-dihydro-4-oxonaphthyridine derivatives
GB2202743B (en) Topical antifungal composition
AU529597B2 (en) 4-thia-1-aza-bicyclo-(3,2,0)-heptane and azetidin-2-one derivatives
IL95172A0 (en) Topical spironolactone composition
PH25425A (en) Vitamin e composition with imprved absorption
NZ187103A (en) Topical composition comprising dithranol
AU508738B2 (en) 8-oxo-3-oxa-l-azabicycio [4,2,0] - cotane derivatives
ZA906970B (en) Topical,antiinflammatory compositions with minimal systemic absorption
AU5870090A (en) Topical formulations
PT84132A (en) Topical antiinflammatory compositions
AU575038B2 (en) Aminoglycoside derivatives, eg 2'n-palmitoyl-kasugamycin
AU4023085A (en) 1,2,4-triazacycloalkadiene derivatives
AU529932B2 (en) 3:,4:-diepi-4:-0-methyl-daunorubicin and derivatives
AU5128785A (en) Triazolo-(3,2-c) perhydroxazin-8-one derivatives
GB8825784D0 (en) Topical composition
GB8828016D0 (en) Topical composition